glp-1 pill news The FDA approved a new from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication New GLP-1 pill orforglipron outperforms

Prior to joining the Posts shopping team in 2023, Kendall previously held positions at Apartment Therapy and at Dotdash Merediths Travel + Leisure and Departures magazines

ALSO READ: Food Systems Largest Violators Of Planetary Limits: 2025 Eat-lancet Commission 9

After consulting with a weight loss physician, I hesitantly started taking a glucagon-like peptide-1 (GLP-1) receptor agonist (Zepbound, in my case) approximately two years ago, and, in short, its been life-changing for me in the best way

JM self-reports that his lifestyle could be improved in terms of both diet and physical activity, and interventions aimed at achieving weight loss would be beneficial

Myth #4: GLP-1 agonists are only for diabetics There is a widespread belief that GLP-1 agonists are exclusively for people with diabetes, leading to confusion about their use in weight loss for non-diabetic individuals

The patients who will do best on these medications over the long term are those who use them within a framework that protects lean mass, supports metabolic health, and addresses the behavioural and physiological underpinnings of weight regain